Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Taiwan Bulk Drug Production Drives Healthy First Five Months

This article was originally published in PharmAsia News

Executive Summary

Taiwan's bulk-drug production increased by more than a third for the first five months of this year, leading to an overall 6.7 percent increase in pharmaceutical production, according to Industry and Technology Intelligence Services. During the period, ITIS said, the value of the production rose to $759.2 million. Production of Western pharmaceuticals rose only 0.9 percent between January and May, the poor growth rate blamed on government policy that adjusted co-payments for drugs from that sector. An ITIS analyst said he expected the industry's overall production to continue to experience stable growth for the rest of this year, led again by an expected surge in active pharmaceutical ingredients exports. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts